Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Mitsubishi Tanabe Pharma seeks additional indication for Tenelia in Japan

Feb. 27, 2013

SBC-103 shows dose-dependent HSD reductions in MPS-III B mouse model

Feb. 26, 2013

BioMarin presents clinical results for two novel enzyme replacement therapies

Feb. 26, 2013

Sihuan Pharmaceutical cleared to conduct study of DPP IV inhibitor in China

Feb. 26, 2013

EMA confirms decision on VIVUS' MAA for obesity treatment

Feb. 25, 2013

Daiichi Sankyo discloses new hypoglycemic agents

Feb. 25, 2013

Novo Nordisk plans launch of Tresiba in Japan

Feb. 25, 2013

Zeria announces the Japanese launch of agent for hypophosphatemia

Feb. 25, 2013

University of Colorado and Orphan Technologies expand collaboration

Feb. 25, 2013

Genz-682452 shows potential as adjuvant therapy for Fabry disease

Feb. 22, 2013

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...